MedTrace Logo

Tolerance of Healthy Infants Fed Infant Formulas

NCT02401217 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 126

Last updated 2016-01-12

No results posted yet for this study

Summary

The primary objective of this study is to assess the comparative gastrointestinal tolerance of normal term infants to two experimental milk-based powdered formulas compared with a standard milk-based powdered formula.

Conditions

  • Gastrointestinal Tolerance

Interventions

OTHER

Phase 1- Arm 1 Infant Formula

Powder infant formula

OTHER

Phase 2- Arm 2 Infant Formula

Powder infant formula

OTHER

Phase 2- Arm 3 Infant Formula

Powder infant formula

Sponsors & Collaborators

  • Abbott Nutrition

    lead INDUSTRY

Principal Investigators

  • Marlene Borschel, PhD, RD · Abbott Nutrition

Study Design

Allocation
RANDOMIZED
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Max Age
30 Days
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-04-30
Primary Completion
2015-09-30
Completion
2015-09-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02401217 on ClinicalTrials.gov